NEW YORK (GenomeWeb News) – The Women and Infants Hospital of Rhode Island will be using funding from genetic testing firm Natera to study the use of the company's prenatal blood test for Down syndrome and other chromosomal abnormalities in a general clinical setting.

Investigators at the hospital plan to focus their efforts on finding out how much information and education women in the general pregnancy population need about the test, called Panorama, which has been used so far been used to screen women in high-risk groups, the hospital said today.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

A new analysis examines the gender gap among paper authors in the sciences and says it may take decades or more to close.

Researchers have uncovered signals of selection that may enable the Bajau people to free five hundreds of feet deep, Reuters reports.

In Science this week: paternally inherited cis-regulatory structural variants in autism, and more.

A new report outlines issues facing the implementation of personalized medicine in the UK, the Independent reports.